LU74411A1 - - Google Patents

Info

Publication number
LU74411A1
LU74411A1 LU74411A LU74411A LU74411A1 LU 74411 A1 LU74411 A1 LU 74411A1 LU 74411 A LU74411 A LU 74411A LU 74411 A LU74411 A LU 74411A LU 74411 A1 LU74411 A1 LU 74411A1
Authority
LU
Luxembourg
Application number
LU74411A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74411A1 publication Critical patent/LU74411A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
LU74411A 1975-02-24 1976-02-23 LU74411A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752508312 DE2508312A1 (de) 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden

Publications (1)

Publication Number Publication Date
LU74411A1 true LU74411A1 (en:Method) 1976-08-13

Family

ID=5939872

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74411A LU74411A1 (en:Method) 1975-02-24 1976-02-23

Country Status (12)

Country Link
US (1) US4082911A (en:Method)
JP (1) JPS51125382A (en:Method)
BE (1) BE838879A (en:Method)
CA (1) CA1065315A (en:Method)
CH (1) CH626093A5 (en:Method)
DE (1) DE2508312A1 (en:Method)
DK (1) DK138900C (en:Method)
FR (1) FR2301536A1 (en:Method)
GB (1) GB1542442A (en:Method)
LU (1) LU74411A1 (en:Method)
NL (1) NL7601625A (en:Method)
SE (1) SE7602109L (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53108986A (en) * 1977-03-02 1978-09-22 Mitsui Toatsu Chem Inc Preparation of nucleosides and nucleotides
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
US4195176A (en) * 1977-10-11 1980-03-25 Warner-Lambert Company Imidazole compounds, methods for their production and conversion of said compounds into (R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
JPH029511U (en:Method) * 1988-06-21 1990-01-22
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
CA2091732C (en) * 1992-07-08 1998-07-21 Anica Markovac A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
JPH07276137A (ja) * 1994-03-31 1995-10-24 Osaka Diamond Ind Co Ltd 切削・研削用工具
DE19513330A1 (de) * 1995-04-03 1996-10-10 Schering Ag Neues Verfahren zur Herstellung von Nucleosiden
PY0111577A (es) 2000-05-23 2017-01-02 Idenix Cayman Ltd Métodos y composiciones para el tratamiento del virus de la hepatitis c
AP2006003708A0 (en) 2000-05-26 2006-08-31 Idenix Cayman Ltd Methods and compositions for treating flavivirusesand pestiviruses
CN1678326A (zh) 2002-06-28 2005-10-05 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2'-c-甲基-3'-o-l-缬氨酸酯核糖呋喃基胞苷
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
RU2005118421A (ru) 2002-11-15 2006-01-20 Айденикс (Кайман) Лимитед (Ky) 2'-разветвленные нуклеозиды и мутация flaviviridae
PL377287A1 (pl) 2002-12-12 2006-01-23 Idenix (Cayman) Limited Sposób wytwarzania 2'-rozgałęzionych nukleozydów
US7038038B2 (en) * 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US7595390B2 (en) 2003-04-28 2009-09-29 Novartis Ag Industrially scalable nucleoside synthesis
RU2361875C2 (ru) 2003-06-30 2009-07-20 Айденикс (Кайман) Лимитед СИНТЕЗ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
AT502635A1 (de) * 2005-11-09 2007-05-15 Saischek Und Partner Meg Neue 1,3-dithioverbindungen, verfahren zu deren herstellung und ihre verwendung
JP5254033B2 (ja) 2005-12-23 2013-08-07 イデニク プハルマセウティカルス,インコーポレイテッド 分岐型ヌクレオシドを調製するための合成中間体の製造方法
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
HUE055911T2 (hu) 2008-05-15 2021-12-28 Celgene Corp Citidin-analógokat tartalmazó orális készítmények, és eljárások azok alkalmazására
WO2010014883A2 (en) 2008-08-01 2010-02-04 Dr. Reddy's Laboratories Ltd. Azacitidine process and polymorphs
EP2324042B1 (en) * 2008-08-06 2012-11-28 Sicor, Inc. Process for preparing azacytidine intermediate
AU2009279461B2 (en) * 2008-08-08 2014-01-23 Scinopharm Taiwan, Ltd. Process for making 5-azacytosine nucleosides and their derivatives
WO2010129211A2 (en) * 2009-04-27 2010-11-11 Dr. Reddy's Laboratories Ltd. Preparation of decitabine
JP6289361B2 (ja) 2011-03-31 2018-03-07 セルジーン インターナショナル サルル 5−アザシチジンの合成
CN108239128B (zh) * 2016-12-23 2019-03-29 江苏奥赛康药业股份有限公司 β-核苷类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354160A (en) * 1965-07-22 1967-11-21 Hoffmann La Roche Tri-lower alkyl-silyl-5-fluoropyrimidines
US3352849A (en) * 1965-10-24 1967-11-14 Merck & Co Inc 6-aza-2'-deoxyuridines
SU452961A3 (ru) * 1969-04-11 1974-12-05 Шеринг Аг. (Фирма) Способ получени пиримидиннуклеозидов
DE2122991C2 (de) * 1971-05-04 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden

Also Published As

Publication number Publication date
DK77176A (da) 1976-08-25
DK138900C (da) 1979-04-30
CA1065315A (en) 1979-10-30
GB1542442A (en) 1979-03-21
DK138900B (da) 1978-11-13
DE2508312C2 (en:Method) 1987-10-29
CH626093A5 (en:Method) 1981-10-30
NL7601625A (nl) 1976-08-26
US4082911A (en) 1978-04-04
JPS6139318B2 (en:Method) 1986-09-03
FR2301536A1 (fr) 1976-09-17
FR2301536B1 (en:Method) 1979-07-27
SE7602109L (sv) 1976-08-25
DE2508312A1 (de) 1976-09-02
JPS51125382A (en) 1976-11-01
BE838879A (fr) 1976-08-24

Similar Documents

Publication Publication Date Title
FR2313819B1 (en:Method)
JPS54147755U (en:Method)
FR2298317B1 (en:Method)
FR2320642B1 (en:Method)
JPS5638903B2 (en:Method)
JPS562826Y2 (en:Method)
CS171131B1 (en:Method)
CS173324B1 (en:Method)
CS172232B1 (en:Method)
CS171797B1 (en:Method)
CS176761B1 (en:Method)
JPS5291432U (en:Method)
JPS5196561U (en:Method)
JPS51152877U (en:Method)
CS171632B1 (en:Method)
JPS51161395U (en:Method)
CS172160B1 (en:Method)
CH597036A5 (en:Method)
CH611056A5 (en:Method)
CH614079A5 (en:Method)
CH616298GA3 (en:Method)
CH608738A5 (en:Method)
CH596119A5 (en:Method)
CH607829A5 (en:Method)
CH600962A5 (en:Method)